Meet our featured StageBio pathologist,
Dr Lemarchand from Germany!

Thomas Xavier Lemarchand, DVM, PhD, DECVP, DESVpath, Director of Digital and Quantitative Pathology.

How long have you worked with StageBio?

Over 8 years, ever since our Freiburg team joined StageBio in 2020; so, about half with TPL Path labs GmbH, about half with StageBio.

What are your primary interests within the Pathology space?  

I am a generalist and love to touch upon many areas, since diversity and change is always fun. I identify myself as belonging to molecular biologists, notably for nucleic acid work and new therapeutic modalities. I once hesitated to become an immunologist during my research on SAIDS and leprosy or a biomarker specialist when heading the biomarker department in Citoxlab, now CRL. I could define myself as a developer, progressist or a “transformation guy” (in our venerable pathology specialty) and mainly an experimental molecular pathologist, although working in safety can bring many unexpected and intriguing findings. For 5 years, I led and then became a team member of the Pathology 2.0 group of the ESTP, an interest group on new roles of pathologists. We are also a center for tissue cross reactivity evaluation of novel antibody-based products, a safety screening study of his own, using frozen normal or pathologic human and animal model tissues, the test item being the primary antibody of the immunohistochemistry assay.

What are your most recent work accomplishments?

Quite recently, I actively contributed with several colleagues to a review paper on in situ hybridization use in experimental and toxicologic pathology, and it was awarded by the tox path community, which is kind of cool! We also have two papers just published in MDPI journals in wound healing highlighting the 3R and Artificial intelligence value in quantitative pathology with a long-standing client appreciating our professionalism and quality with co-author Fabian Kukla in the second paper.  Additionally, I just finished a large project helping select new oncologic indications of novel therapies, which included helping to find new targets for hard-to-treat cancers. Lastly, I contributed to the implementation of a digital image management system and other tools for StageBio, preparing for further digital evolution for our team and clients.

What do you like about the StageBio culture?

The high scientific level, nice level of exchanges and communication amongst the pathologists, and consequently, the highest quality of pathology work. I enjoy my local and remote colleagues, and of course, the US pathology and digital imaging crew. Altogether, since clients and team members are the building blocks of the development of our lives, I not only appreciate but endorse the StageBio culture of team spirit, value of producing quality work for our clients, and scientific expertise we live every day.

What do you like to do on the weekends?

Because my work is indoors, mostly introspective and in front of a microscope and/or a large computer screen, my favorite activities during the weekend include outdoor activities, such as exploring local city markets in Freiburg Germany or Evreux, France, and spending time in nature, like hiking, climbing, biking, jogging, or swimming in the lakes of the Black Forest with family and friends. I also like helping my refugee friends, who need support and contacts to better integrate into Europe. I have very much appreciated this aspect myself, especially when I was an immigrant in North America. 

To learn more about StageBio, visit us here or contact our team.